Erschienen in:
01.07.2023 | Research Letter
Recombinant Varicella Zoster vaccine in haemodialysis facilities: adherence and safety
verfasst von:
Francesca K. Martino, Stefano Pini, Giuseppe Scaparrotta, Marilena Schirinzi, Maddalena Gnappi, Antonio Fragasso, Ruggero Zanella, Elena Naso, Maria Loreta De Giorgi, Gianni Carraro, Federico Nalesso, Lorenzo A. Calò
Erschienen in:
Journal of Nephrology
|
Ausgabe 7/2023
Einloggen, um Zugang zu erhalten
Excerpt
Varicella Zoster (VZ) infection is a significant health problem in the general population, especially in elderly and frail patients, who have a higher risk of severe complications [
1]. In addition, the related antiviral treatment in this class of patients showed limited efficacy and the need for a long treatment period, with a consequent increase in side effects and viral resistance. …